A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

NCT01175226 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinovirus

Interventions

DRUG: BTA798
DRUG: Placebo

Sponsor

Biota Scientific Management Pty Ltd